Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2012-02-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbrc.2012.01.092PMID 22306012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of N-terminally linked protein and peptide dimers by native chemical ligation.

  2010cited by this paper
• Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP)

  2010cited by this paper
• Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigens.

  2008cited by this paper
• Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.

  2006cited by this paper
• Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.

  2006cited by this paper
• Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

  2006cited by this paper
• Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-gamma production and cross-strain reactivity.

  2006cited by this paper
• Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995–2000

  2005cited by this paper
• Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

  2005cited by this paper
• Tetramolecular immune complexes are more efficient than IVIg to prevent antibody‐dependent in vitro and in vivo phagocytosis of blood cells

  2004cited by this paper
• Fc receptor biology.

  2003cited by this paper
• F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

  2003cited by this paper
• Roles of Fc receptors in autoimmunity

  2002cited by this paper
• Intravenous immunoglobulins neutralize blocking antibodies in Guillain‐Barré syndrome

  2002cited by this paper
• Immune pathophysiology of autoimmune thrombocytopenic purpura.

  2002cited by this paper
• Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

  2001cited by this paper
• Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.

  2001cited by this paper
• Mononuclear cells ingest E. coli opsonized by investigational intravenous immunoglobulin preparations in the absence of complement more efficiently than polymorphonuclear phagocytes.

  2001cited by this paper
• Fc receptor blockade and immune thrombocytopenic purpura.

  2000cited by this paper
• Suppressive effect of intravenous immunoglobulins on the activity of interleukin-1

  1994cited by this paper
• Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.

  1994cited by this paper
• Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura

  1993cited by this paper
• Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.

  1993cited by this paper
• Treatment of Guillain‐Barré syndrome with high‐dose gammaglobulin

  1988cited by this paper
• Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy.

  1985cited by this paper
• High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

  1981cited by this paper

• Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies

  2024cites this paper
• Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: lessons from therapeutic modalities targeting Fcγ receptors.

  2020cites this paper
• Engineered hexavalent Fc proteins with enhanced Fc-gamma receptor avidity provide insights into immune-complex interactions

  2018cites this paper
• Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation

  2018cites this paper
• Influence of immunoglobulin G-glycan and subclass variation on antibody effector functions

  2017cites this paper
• Mouse models of autoimmune diseases: immune thrombocytopenia.

  2015cites this paper
• T cell immune abnormalities in immune thrombocytopenia

  2014cites this paper
• RIIb in human macrophages γ sialylation and Fc R-mediated phagocytosis by IVIg is independent of IgG-Fc γ Inhibition of Fc

  2014cites this paper
• Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.

  2014cites this paper
• Understanding the role of antibodies in murine infections with Heligmosomoides (polygyrus) bakeri: 35 years ago, now and 35 years ahead

  2014cites this paper